Rheumatoid arthritis (RA)
Merete Hetland, MD, PhD
Rigshospitalet
Glostrup, Denmark
Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Terminated, December 31, 2021); Danbio: MLH has chaired the steering committee of the Danish Rheumatology Quality Registry (DANBIO, DRQ), which receives public funding from the hospital owne (Terminated, August 31, 2022); Eli Lilly: Grant/Research Support (Terminated, December 31, 2021); MEDAC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2022); Novartis: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Terminated, July 1, 2022), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 1, 2022); Sandoz: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Ted Mikuls, MD
University of Nebraska Medical Center
Omaha, NE, United States
Disclosure(s): Elsevier: Royalties (Ongoing); Horizon Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Ongoing); UCB Pharma: Consultant (Ongoing); Wolters Kluwer Health (UpToDate): Royalties (Ongoing)
Eiichi Tanaka, MD, PhD
Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine
Tokyo, Japan
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Asahi Kasei: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Astellas Pharma: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Ayumi Parmaceutical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chugai Parmaceutical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Daiichi-Sankyo: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eisai: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gilead: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Kyowa Oharma Chemical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Mitsubishi Tanabe Pharma: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Mochida Pharmaceutical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Nippon Kayaku: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Takeda Pharmaceutical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teijin Pharma: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Viatris: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Registry data provides critical insights into real-world treatment for RA. In this session, key observations in RA treatment in U.S., Danish, and Japanese registries will be discussed with a focus on comorbidities and safety.
Speaker: Ted Mikuls, MD – University of Nebraska Medical Center
Speaker: Merete Hetland, MD, PhD – Rigshospitalet
Speaker: Eiichi Tanaka, MD, PhD – Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine